Three 20(S)-protopanaxatriol-type saponins, ginsenoside-Rg1 (1), notoginsenoside-R1 (2), and ginsenoside-Re (3), were transformed by the fungus Absidia coerulea (AS 3.3389). Compound 1 was converted into five metabolites, ginsenoside-Rh4 (4), 3beta,2beta,25-trihydroxydammar-(E)-20(22)-ene-6-O-beta-D-glucopyranoside (5), 20(S)-ginsenoside-Rh1 (6), 20(R)-ginsenoside-Rh1 (7), and a mixture of 25-hydroxy-20(S)-ginsenoside-Rh1 and its C-20(R) epimer (8). Compound 2 was converted into 10 metabolites, 20(S)-notoginsenoside-R2 (9), 20(R)-notoginsenoside-R2 (10), 3beta,12beta,25-trihydroxydammar-(E)-20(22)-ene-6-O-beta-D-xylopyranosyl-(1-->2)-beta-D-glucopyranoside (11), 3beta,12beta-dihydroxydammar-(E)-20(22),24-diene-6-O-beta-D-xylopyranosyl-(1-->2)-beta-D-glucopyranoside (12), 3beta,12beta,20,25-tetrahydroxydammaran-6-O-beta-D-xylopyranosyl-(1-->2)-beta-D-glucopyranoside (13), and compounds 4-8. Compound 3 was metabolized to 20(S)-ginsenoside-Rg2 (14), 20(R)-ginsenoside-Rg2 (15), 3beta,12beta,25-trihydroxydammar-(E)-20(22)-ene-6-O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside (16), 3beta,12beta-dihydroxydammar-(E)-20(22),24-diene-6-O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside (17), 3beta,12beta,20,25-tetrahydroxydammaran-6-O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside (18), and compounds 4-8. The structures of five new metabolites, 10-13 and 16, were established by spectroscopic methods.
Citing Articles
Production of rare ginsenosides by biotransformation of Panax notoginseng saponins using Aspergillus fumigatus.
Yang L, Lin D, Li F, Cui X, Lou D, Yang X
Bioresour Bioprocess. 2024; 11(1):81.
PMID: 39133231
PMC: 11319572.
DOI: 10.1186/s40643-024-00794-0.
Rare ginsenosides: A unique perspective of ginseng research.
Fan W, Fan L, Wang Z, Mei Y, Liu L, Li L
J Adv Res. 2024; 66:303-328.
PMID: 38195040
PMC: 11674801.
DOI: 10.1016/j.jare.2024.01.003.
Characterization of Ginsenosides from the Root of by Integrating Untargeted Metabolites Using UPLC-Triple TOF-MS.
Sun Y, Fu X, Qu Y, Chen L, Liu X, He Z
Molecules. 2023; 28(5).
PMID: 36903315
PMC: 10004652.
DOI: 10.3390/molecules28052068.
Highly Regioselective Biotransformation of Protopanaxadiol-type and Protopanaxatriol-type Ginsenosides in the Underground Parts of to 18 Minor Ginsenosides by .
Liang Y, Guo M, Li Y, Shao L, Cui X, Yang X
ACS Omega. 2022; 7(17):14910-14919.
PMID: 35557696
PMC: 9089366.
DOI: 10.1021/acsomega.2c00557.
Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.
Chen Z, Zhang Z, Liu J, Qi H, Li J, Chen J
Front Cell Infect Microbiol. 2022; 12:853981.
PMID: 35548468
PMC: 9084182.
DOI: 10.3389/fcimb.2022.853981.
-mediated biotransformation of notoginsenoside R1 into 25-OH-20(/)-R2 with elevated cardioprotective effect against DOX-induced cell injury.
Liu J, Xin Y, Qiu Z, Zhang Q, He T, Qiu Y
RSC Adv. 2022; 12(21):12938-12946.
PMID: 35497008
PMC: 9049007.
DOI: 10.1039/d2ra01470j.
New dammarane-type triterpenoid saponins from saponins.
Li Q, Yuan M, Li X, Li J, Xu M, Wei D
J Ginseng Res. 2020; 44(5):673-679.
PMID: 32913396
PMC: 7471129.
DOI: 10.1016/j.jgr.2018.12.001.
Advances in the chemistry, pharmacological diversity, and metabolism of 20()-ginseng saponins.
Wang C, Liu J, Deng J, Wang J, Weng W, Chu H
J Ginseng Res. 2020; 44(1):14-23.
PMID: 32095093
PMC: 7033361.
DOI: 10.1016/j.jgr.2019.01.005.
Genome sequencing of strain Cellulosimicrobium sp. TH-20 with ginseng biotransformation ability.
Zheng F, Zhang W, Chu X, Dai Y, Li J, Zhao H
3 Biotech. 2017; 7(4):237.
PMID: 28698996
PMC: 5505874.
DOI: 10.1007/s13205-017-0850-2.
Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action.
Xu D, Huang P, Yu Z, Xing D, Ouyang S, Xing G
Front Neurol. 2015; 5:274.
PMID: 25620952
PMC: 4288044.
DOI: 10.3389/fneur.2014.00274.
Complete (1)H-NMR and (13)C-NMR spectral analysis of the pairs of 20(S) and 20(R) ginsenosides.
Yang H, Kim J, Kim S, Yoo Y, Sung S
J Ginseng Res. 2014; 38(3):194-202.
PMID: 25378994
PMC: 4213847.
DOI: 10.1016/j.jgr.2014.05.002.
Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.
Niu T, Smith D, Yang Z, Gao S, Yin T, Jiang Z
Pharm Res. 2012; 30(3):836-46.
PMID: 23254888
PMC: 4372807.
DOI: 10.1007/s11095-012-0925-z.
Ginsenosides from American ginseng: chemical and pharmacological diversity.
Qi L, Wang C, Yuan C
Phytochemistry. 2011; 72(8):689-99.
PMID: 21396670
PMC: 3103855.
DOI: 10.1016/j.phytochem.2011.02.012.
Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.
Jia L, Zhao Y, Liang X
Curr Med Chem. 2009; 16(22):2924-42.
PMID: 19689273
PMC: 2754208.
DOI: 10.2174/092986709788803204.